Frencken's stock price surged 4.98% during intraday trading on Wednesday, reflecting strong investor optimism about the company's prospects.

The rally comes as analysts expect Frencken's revenue to improve in 2026, with the technology services provider positioned as a key beneficiary of the ongoing recovery in the semiconductor industry. Additionally, the company's analytical and life sciences segment is anticipated to see revenue growth in coming quarters following the planned introduction of new products.

Maybank Securities maintains a buy rating on Frencken with a target price of S$3.40, further supporting the positive sentiment driving the stock's upward movement.